Supply Center Health Care

Supply Center Healthcare Bayer berlokasi di Cimanggis, Jawa Barat memproduksi produk-produk consumer healh. Selain memenuhi kebutuhan pasar Indonesia, saat ini mengekspor 73% produknya ke 22 negara dengan peraturan farmasi yang ketat: Filipina, Thailand, Hongkong, Korea, Singapura, Brunei, Vietnam, Malaysia, Pakistan, Kambodia, Taiwan, Myanmar, Australia, Selandia Baru, Inggris, Swedia, Turki, Rumania, Hungaria, Finlandia, Kanada, Amerika Serikat.

Kami senantiasa berkomitmen untuk menjaga mutu produk dan kepuasan pelanggan dengan memenuhi berbagai standar internasional dan memiliki berbagai sertifikasi: Global Good Manufacturing Practice, Praktik Perlindungan Lingkungan, Halal, HACCP, dan Pelatih Pendidikan Vokasi.

Selain itu, kami aktif berkontribusi dalam meningkatkan perekonomian Indonesia melalui ekspor produk-produk kami. Pada tanggal 27 Maret 2019 bersama dengan Pemerintah merayakan ekspor produk perawatan kesehatan kami yang ke 3.000 ke Eropa, dengan nilai total Rp3,9 triliun.

Dalam bidang keberlanjutan, kami berkomitmen mengurangi emisi karbon dan energi terbarukan di Indonesia. Kami mendukung Indonesia mencapai target penurunan emisi gas rumah kaca sebesar 31,89 persen pada 2030. Di tahun 2024 kami memasang solar panel atap seluas 1,66 hektar dengan menggunakan 3.770 modul fotovoltaik. PLTS atap ini menghasilkan 2.054 kWp yang memenuhi 43% kapasitas daya terpasang. Hingga saat ini, fasilitas solar panel atap kami adalah yang terbesar untuk industri farmasi multinasional di Indonesia. 

Situated in Cimanggis, West Java, the Bayer Healthcare facility manufactures consumer health products. Beyond catering to the domestic Indonesian market, it presently exports a substantial 73% of its output to 22 nations that enforce the most rigorous pharmaceutical standards worldwide, including the Philippines, Thailand, Hong Kong, Korea, Singapore, Brunei, Vietnam, Malaysia, Pakistan, Cambodia, Taiwan, Myanmar, Australia, New Zealand, the United Kingdom, Sweden, Turkey, Romania, Hungary, Finland, Canada, and the United States.

We are consistently committed to maintaining product quality and customer satisfaction by adhering to various international standards and possessing numerous certifications: Global Good Manufacturing Practice, Environmental Protection Practices, Halal, HACCP, and Vocational Training.

Furthermore, we actively contribute to enhancing Indonesia's economy through the export of our products. On March 27, 2019, together with the Government, we celebrated our 3,000th export of healthcare products to Europe, with a total value of Rp3.9 trillion.

In the realm of sustainability, we are committed to reducing carbon emissions and promoting renewable energy in Indonesia. We support Indonesia's goal of reducing greenhouse gas emissions by 31.89% by 2030. In 2024, we installed rooftop solar panels covering an area of 1.66 hectares, utilizing 3,770 photovoltaic modules. This rooftop solar power system generates 2,054 kWp, meeting 43% of our installed capacity. To date, our rooftop solar panel facility is the largest among multinational pharmaceutical industries in Indonesia.